Logo Image

Authors

Karen Appold
Kristina Fiore
Mark J. Fuerst
Melissa Young, MD
Payal Kohli, MD
Robert P. Blereau, MD
Samantha J. Peterson
Susan Weimer, DPT, PT
Thomas P. Bravo, MD
Timothy S. Reid, MD
Veronica Hackethal, MD, MSc
Melissa Young, MD
Practical Cardiology Editorial Staff
Endocrinology Network Editorial Staff
Jeff Craven
Harold Bays, MD
Gretchen Cuda Kroen
Katie Falloon, MD
Latest Article

SEQUENCE: Comparing Risankizumab to Ustekinumab in Crohn’s Disease

Ustekinumab is currently the only anti-interleukin therapy approved for the treatment of ulcerative colitis, but given the superior performance of risankizumab in CD patients, it will be interesting to see data regarding its efficacy in UC.

Jeff R. Peterson, MD
Keith C. Ferdinand, MD, Tulane University School of Medicine
Jane Davis, DNP
Latest Article

Sick Day Rules in Nephrology, with Kim Zuber, PA-C, and Jane Davis, DNP

In their latest column, Kim Zuber, PA-C, and Jane Davis, DNP, break down the concept of "sick day rules" and what this means for providers caring for those with kidney disease.

Sophia Abene
Latest Article

The Long COVID Patient Journey: A Complex and Uncertain Road

Navigating the long road of Long COVID requires more than just recovery from an infection, it demands specialized, multifaceted care to address persistent and often invisible neurological symptoms.

Meg Dalton

Writer at Yale University

Latest Article

The cure for cystic fibrosis might start in the womb

In a new study, Yale researchers develop a method that has the potential to cure cystic fibrosis prior to birth.

Mallory Locklear, PhD

Managing Editor—Science, Research, and Education at Yale School of Medicine.

Latest Article

How an Essential Vitamin B-Derived Nutrient Concentrates in Mitochondria

Yale researchers reveal how essential coenzyme A is imported into mitochondria, shedding light on its role in metabolic diseases and potential treatments.

Antonio Bianco, MD, PhD
Alex Hillenbrand
Alex Hillenbrand

Alex Hillenbrand is an assistant editor for HCPLive. She earned her BA in English from Lafayette College in 2023 and went on to write for pop culture, entertainment, and sports media outlets before joining MJH Life Sciences in 2025. In her free time, Alex enjoys cooking, going on walks, and meeting new people. Contact her at mjhlifesciences.com.


Latest Article

Kidney Compass: Rituximab Cuts Relapse Risk in MCD, FSGS in TURING Trial

The phase 3 TURING trial found rituximab slashed relapse rates in adults with minimal change disease and FSGS, offering a steroid-sparing alternative.

Oussama Wazni, MD | Credit: HCPLive
Oussama Wazni, MD

Oussama Wazni, MD, is the vice chairman of Cardiovascular Medicine and section head of Cardiac Electrophysiology at the Cleveland Clinic.

Latest Article

Oussama Wazni, MD, MBA: OPTION Trial and the Role of LAAC in Atrial Fibrillation

Oussama Wazni, MD, discusses the results of the OPTION trial examining LAAC in atrial fibrillation as well as its reception as AHA 2024.

Grace Halsey
Gregory W Rutecki, MD
Gregory W. Rutecki, MD